Diane Scudiery

A phase II trial of peg-L-asparaginase in the treatment of non-hodgkins lymphoma

C. Spurr, H. Muss, P. Zekan, 1990, Investigational New Drugs.

Adenosine deaminase deficiency with late onset of recurrent infections: response to treatment with polyethylene glycol-modified adenosine deaminase.

M. Hershfield, R. Sorensen, Y. Levy, 1988, The Journal of pediatrics.